...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Use of the gel agglutination technique for determination of fetomaternal hemorrhage.
【24h】

Use of the gel agglutination technique for determination of fetomaternal hemorrhage.

机译:凝胶凝集技术用于确定胎儿母体出血的用途。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Adequate administration of Rh immune globulin requires an accurate determination of the number of D-positive cells in the circulation of D-negative women. Although several tests have been described for the detection of fetomaternal hemorrhage, there is still a need for a rapid, simple, and clinically relevant screening test. STUDY DESIGN AND METHODS: Serial dilutions of a monoclonal anti-D were incubated with stock solutions (0.2 mL) of adult D-negative red cells in the absence or presence of various amounts of fetal D-positive cells (0.1, 0.2, 0.3, 0.4, and 0.5%). After incubation, the supernatants were tested against D-positive red cells by using the new, gel agglutination technique (GAT). After the GAT was adapted to detect D-positive cells at concentrations of > or = 0.2 percent, unselected postpartum samples from D-negative women (n = 420) who delivered D-positive infants were analyzed by both the new test and the Kleihauer-Betke test (KBT). RESULTS: Three of a total of 420 postpartum samples were positive (> or = 0.4% fetal cells), and 406 were negative in both tests. One had 0.5-percent fetal cells in the KBT and gave negative results in the GAT. The latter test was, however, performed after administration of Rh immune globulin. The KBT gave false-positive results in two cases, because of hereditary persistence of hemoglobin F, and the GAT gave a false-positive reaction in one case because of a maternal weak D variant. In the remaining seven cases, the KBT results were only weakly positive (0.2%) and could not be attributed solely to D positive red cells. CONCLUSION: The GAT is suited for routine screening. It provides rapid and specific detection of D-positive red cells at clinically relevant concentrations. The test may (rarely) yield false-negative results due to insufficient administration of Rh immune globulin before testing.
机译:背景:Rh免疫球蛋白的充分给药需要准确测定D阴性女性循环中D阳性细胞的数量。尽管已经描述了几种检测胎儿母体出血的测试方法,但是仍然需要快速,简单和临床相关的筛查测试。研究设计和方法:在不存在或存在各种数量的胎儿D阳性细胞(0.1、0.2、0.3、1.0、0.2、0.3、1.0、0.2、0.3、1.0、0.5、0.5、0.5、0.5、0.5、0.5、0.5、0.5、0.5%,0.1%,0.5%,0.5%,1.0%,0.5%,1.0%,0.5%,0.5%,0.1%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5%,0.5% 0.4和0.5%)。孵育后,使用新的凝胶凝集技术(GAT)测试上清液对D阳性红细胞的抵抗力。在将GAT调整为以>或= 0.2%的浓度检测D阳性细胞后,通过新测试和Kleihauer-A分析了D阴性妇女(n = 420)分娩D阳性婴儿的未选产后样品。 Betke测试(KBT)。结果:总共420份产后样品中有3份阳性(>或= 0.4%的胎儿细胞),而406份阴性。其中一个在KBT中有0.5%的胎儿细胞,而在GAT中却给出了阴性结果。但是,后者的试验是在给予Rh免疫球蛋白后进行的。由于血红蛋白F的遗传性持久性,KBT在2例中给出了假阳性结果,而在1例中,由于母体弱D变体,GAT给出了假阳性反应。在其余的七个案例中,KBT结果仅是弱阳性(0.2%),不能仅归因于D阳性红细胞。结论:GAT适合常规筛查。它提供了临床相关浓度的D阳性红细胞的快速,特异性检测。由于在测试前未充分施用Rh免疫球蛋白,该测试可能(很少)产生假阴性结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号